Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4119803 | 0.77 | — | — | |
| SCHEMBL8909344 | 0.71 | TSHR (0.52) | TSHRALDH1A1FAAH | |
| SCHEMBL28591833 | 0.70 | TSHR (0.48) | TSHRALDH1A1FAAH | |
| SCHEMBL1341309 | 0.68 | FAAH (0.42) | TSHRALDH1A1FAAH | |
| SCHEMBL15519857 | 0.68 | FAAH (0.42) | TSHRALDH1A1FAAH | |
| Hydrazine SCHEMBL11500590 | 0.68 | — | — | |
| Methylamine SCHEMBL27467229 | 0.68 | TSHR (0.88) | TSHRALDH1A1 | |
| SCHEMBL2137 | 0.67 | — | — | |
| SCHEMBL2405672 | 0.67 | TSHR (1.00) | TSHRALDH1A1 | |
| SCHEMBL9420916 | 0.67 | TSHR (1.00) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1606019-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | The University Court of The University of Aberdeen (GB) | 2005-12-21 | — | — | EP | claimed |
| WO-2004078261-A1 | CANNABINOID RECEPTOR INVERSE AGONISTS AND NEUTRAL ANTAGONISTS AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE DISORDERS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) | 2004-09-16 | — | — | WO | claimed |